<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel>
<title>AI News 180m Report｜2026-10-07 09:00–12:00 JST｜Page 12 of 12</title><link>https://ainews.idaeo.ai/180m/20261007-09/index-en-p12.html</link><description>One place for news and notices from 2 countries/regions: Japan, 985 items from 4 sources; Taiwan, 119 items from 9 sources.One edition every 180 minutes: every item from every source received in the period, with the original link.</description><language>en</language>
<item><title>Seven-Minute Workout – Quick Stretches for the Shoulders, Neck, Hips and Back</title><link>https://ainews.idaeo.ai/180m/20261007-09/index-en-p12.html#n3240510</link><guid isPermaLink="true">https://ainews.idaeo.ai/180m/20261007-09/index-en-p12.html#n3240510</guid><pubDate>Wed, 07 Oct 2026 10:00:00 +0900</pubDate><category>Taiwan</category><source url="https://www.careonline.com.tw/2026/10/shoulders-and-neck-stretch-261007.html">照護線上</source><description>An introduction to a 七-minute full-body stretching routine that gently relieves tension in the shoulders, neck, hips and back, along with stress and anxiety.</description></item>
<item><title>台康生技 (6589) submits marketing authorization application to the EU EMA for 420 mg breast cancer drug EG1206A injection – Global Bio &amp; Investment Monthly</title><link>https://ainews.idaeo.ai/180m/20261007-09/index-en-p12.html#n3240570</link><guid isPermaLink="true">https://ainews.idaeo.ai/180m/20261007-09/index-en-p12.html#n3240570</guid><pubDate>Wed, 07 Oct 2026 01:00:00 +0900</pubDate><category>Taiwan</category><source url="https://news.gbimonthly.com/tw/invest/show.php?num=90586&amp;kind=21">環球生技月刊</source><description>台康生技 (6589) announced that on 115年10月6日 it submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for its biosimilar EG1206A (Pertuzumab Biosimilar) 420 mg liquid injection. The drug is used to treat early-stage and metastatic HER2-positive breast cancer. The Phase 第一 clinical trial has been completed, and the Phase 第三 clinical trial was waived; the application has entered the EMA review stage.</description></item>
<item><title>Personnel and Labor Relations Magazine, Regular Issue No. 192</title><link>https://ainews.idaeo.ai/180m/20261007-09/index-en-p12.html#n3239958</link><guid isPermaLink="true">https://ainews.idaeo.ai/180m/20261007-09/index-en-p12.html#n3239958</guid><pubDate>Mon, 05 Oct 2026 13:46:00 +0900</pubDate><category>Japan</category><source url="https://www.mhlw.go.jp/stf/newpage_76577.html">厚生労働省</source><description>The Ministry of Health, Labour and Welfare published “Personnel and Labor Relations Magazine, Regular Issue No. 192.” It includes information on the release of the “Reiwa 8 edition of the Analysis of the Labour Economy” (White Paper on the Labour Economy), among other topics.</description></item>
<item><title>大甲 (2221): The company has been invited to participate in online investor conferences hosted by 中信證券, 合庫證券 and 富邦證券</title><link>https://ainews.idaeo.ai/180m/20261007-09/index-en-p12.html#n3240193</link><guid isPermaLink="true">https://ainews.idaeo.ai/180m/20261007-09/index-en-p12.html#n3240193</guid><pubDate>Wed, 07 Oct 2026 11:22:41 +0900</pubDate><category>Taiwan</category><source url="https://mopsov.twse.com.tw/mops/web/ajax_t05st01?encodeURIComponent=1&amp;step=2&amp;firstin=1&amp;off=1&amp;queryName=co_id&amp;inpuType=co_id&amp;TYPEK=otc&amp;co_id=2221&amp;year=115&amp;month=10&amp;b_date=1&amp;e_date=31&amp;seq_no=1&amp;spoke_time=102241&amp;spoke_date=20261007">公開資訊觀測站</source><description>大甲(2221)公告受邀參加中信證券、合庫證券及富邦證券舉辦之線上法人說明會，分別於10月8日、10月12日及10月13日進行，說明公司營運概況。</description></item>
</channel></rss>
